Albinism
📧 Sign up to get email alerts when something new happens for Albinism.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: FARD (RaDiCo Cohort) (RaDiCo-FARD)
The RaDiCo-FARD clinical trial sponsored by INSERM is currently recruiting, studying a cohort of patients with inherited skin and ectodermal…
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: Implementation of Long-read Sequencing for the Diagnosis of Rare Diseases.
An update describes implementing long-read sequencing to improve diagnosis of rare diseases. The study includes albinism and intellectual di…
-
CLINICAL_TRIALS trial_result · 2026-01-06Clinical Trial Update: Genetic Analysis and Multimodal Retinal Imaging of Asymptomatic Fovea Plana Cases in the General Population [NA]
A completed clinical trial investigated genetic analysis and multimodal retinal imaging in asymptomatic fovea plana cases in the general pop…
-
CLINICAL_TRIALS research · 2025-08-19Clinical Trial Update: National Ophthalmic Genotyping and Phenotyping Network (eyeGENE (Registered Trademark)), Stage 3 - Expansion of DNA and Data Repositories for Rare Inherited Ophthalmic Diseases
EyeGENE Stage 3 expansion to broaden DNA and data repositories for rare inherited ophthalmic diseases; study currently recruiting.
-
CLINICAL_TRIALS research · 2025-05-18Clinical Trial Update: Qualitative Study in Patients With Genodermatoses and Healthcare Professionals on Reproductive Counselling
Maastricht University Medical Center is conducting a qualitative study to explore reproductive counseling for patients with genodermatoses a…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-06-11Clinical Trial Update: Vision Response to Dopamine Replacement [Phase 2]
Phase 2 trial update for vision response to dopamine replacement in albinism conditions; study terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2018-05-02Clinical Trial Update: Trial of L-DOPA as a Treatment to Improve Vision in Albinism [Phase 2]
Phase 2 clinical trial evaluating L-DOPA for improving vision in individuals with albinism; results have been posted.
-
CLINICAL_TRIALS trial_result · 2017-11-17Clinical Trial Update: Nitisinone for Type 1B Oculocutaneous Albinism [Phase 1, Phase 2]
Clinical trial update for nitisinone in Type 1B oculocutaneous albinism (Phase 1/2) completed with results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2012-01-26Clinical Trial Update: Oral Pirfenidone for the Pulmonary Fibrosis of Hermansky-Pudlak Syndrome [Phase 2]
Phase 2 trial of oral pirfenidone for Hermansky-Pudlak syndrome-associated pulmonary fibrosis has completed and results have been posted. Th…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Visual Function and Ocular Pigmentation in Albinism
A completed NEI-sponsored clinical trial evaluated visual function and ocular pigmentation in individuals with albinism.